← Open Payments lookup

KRISTYN MOWRY: Open Payments

NPI 1760831846 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$886 in 35 payments from 10 companies in 2025. Trend: 2023 $224 · 2024 $1,152 · 2025 $886

Food & beverage: $886
CompanyPaymentsAmount
Madrigal Pharmaceuticals6$231
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$143
Takeda Pharmaceuticals U.S.A., Inc.4$109
QOL Medical, LLC4$94
Phathom Pharmaceuticals, Inc.5$80
Janssen Biotech, Inc.3$78
Ardelyx, Inc.2$49
Lilly USA, LLC2$43
ABBVIE INC.2$42
PFIZER INC.1$17

Products named: REZDIFFRA, XIFAXAN, Sucraid, VOQUEZNA, TREMFYA, ENTYVIO, IBSRELA, SKYRIZI.

Industry payments across CT — which companies pay providers there.